"10.1371_journal.pone.0037212","plos one","2012-05-18T00:00:00Z","Amy Tong; Steven Y C Tong; Yurong Zhang; Supaporn Lamlertthon; Batu K Sharma-Kuinkel; Thomas Rude; Sun Hee Ahn; Felicia Ruffin; Lily Llorens; Ganesh Tamarana; Donald Biek; Ian Critchley; Vance G Fowler","Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America; Duke Clinical Research Institute, Durham, North Carolina, United States of America; Naresuan University, Phitsanulok, Phitsanulok Province, Thailand; Menzies School of Health Research, Darwin, Northern Territory, Australia; Cerexa, Inc., Oakland, California, United States of America","Conceived and designed the experiments: AT DB VGF. Performed the experiments: AT SYCT YZ SL BKS TR SA. Analyzed the data: SYCT GT DB. Contributed reagents/materials/analysis tools: FR. Wrote the paper: AT SYCT DB VGF. Critical review of the manuscript: LL IC.","L.L., G.T., D.B., and I.C. are employees of Cerexa, Inc. V.G.F. has received grants or research support from Astellas Pharma, Inc., Cubist Pharmaceuticals, Merck & Co., Inc., Theravance, Inc., MedImmune, Cerexa, Inc., Pfizer, and the United States National Institutes of Health. He is a consultant for Astellas Pharma, Inc., Biosynexus, Novartis, Cubist Pharmaceuticals, Inimex, Merck & Co., Inc., Galderma, Johnson & Johnson, Medicines Company, Novartis and is on the speakers bureau and advisory committee for Cubist Pharmaceuticals. He has received honoraria from Achaogen, Arpida, Astellas Pharma, Inc., Cubist Pharmaceuticals, Durata, Inhibitex, Leo Pharma, Merck & Co., Inc., Pfizer, Targanta, Theravance, Inc., and Ortho-McNeil. Scientific Therapeutics Information, Inc., provided editorial coordination (which was funded by Forest Research Institute, Inc.). A.T., S.Y.C.T., Y.Z., S.L., B.K.S., T.R., and F.R. have no competing interests to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","05","Amy Tong","AT",13,FALSE,3,7,3,4,TRUE,FALSE,FALSE,0,NA,FALSE
